Farms.com Home   News

Microbiome Research Lays Foundation for Development of Tools to Improve Pig Health

Research into the microbiome of piglets conducted on behalf of Swine Innovation Porc is assisting in creating new tools to increase the productivity of the swine herd. Preliminary results of research being conducted by the Universities of Alberta, Saskatchewan and Guelph in partnership with Swine Innovation Porc, Calpis, Cargill, Phileo, and Evonik indicate the bacteria that live in the gut of piglets influences their overall health and can be used to improve their lifetime productivity.

Dr. Bonita McCuaig, a postdoctoral research fellow with University of Saskatchewan, says the introduction of beneficial bacteria has the potential to improve feed efficiency and piglet health and may reduce the need for antibiotics.

Clip-Dr. Bonita McCuaig-University of Saskatchewan:

The early results suggest that the health outcomes are linked to the microbiome in young piglets and it does look like we will be able to identify some bacteria that are beneficial. A lot of the information generated from this will mostly be applied to create more targeted research.

Once we have these more specific theories, we can generate experiments to test those theories. If we identify a bacteria that we think is beneficial we can perhaps expose young piglets to it and see if it improves their heath compared to piglets that aren’t exposed.

The other thing that I am working on is trying to create a model that will predict whether piglets will become sick based on their microbiome at a young age. Potentially this model could be used to separate piglets with good microbiomes from piglets with bad microbiomes early on in the process but these are still pretty theoretical and would need to be tested further before they could be applied to industry.

Source : Farmscape

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.